News

Aspiro Therapeutics CEO James Lovgren to Speak at Global RESCON Summit 2026

Aspiro Therapeutics to Participate in RESI San Diego 2026

Aspiro Therapeutics to Present at ATS Respiratory Innovation Summit 2026

Aspiro Therapeutics to Attend JPM Week 2026

Aspiro Co-founders Leading $3.8M NIH Study on Early Detection of COPD

Aspiro Therapeutics Establishes Advisory Board to Support Development of Lead Therapy